Pharmaceuticals (137) | Separation Agreements (137)

Browse by Company

4Front Ventures Corp. (1)
Acreage Holdings, Inc. (1)
Adamis Pharmaceuticals Corp (1)
Amag Pharmaceuticals (2)
Amneal Pharmaceuticals, Inc. (6)
Amphastar Pharma (1)
Ampio Pharmaceuticals, Inc. (1)
Angion Biomedica Corp. (3)
ANI Pharma Inc (1)
Aquestive Therapeutics, Inc. (2)
Assertio Holdings, Inc. (4)
ATAI Life Sciences B.V. (1)
Athira Pharma, Inc. (1)
AYTU BIOSCIENCE, INC (1)
Baudax Bio, Inc. (1)
BIODELIVERY SCIENCES INTERNATIONAL INC (1)
Cara Therapeutics, Inc. (1)
Cerecor Inc. (2)
Clearside Biomedical, Inc. (2)
Clever Leaves Holdings Inc. (1)
COGNITION THERAPEUTICS INC (1)
Corcept Therapeutics Incorporated (1)
CorMedix Inc. (2)
Cure Pharmaceutical Holding Corp. (1)
Eloxx Pharmaceuticals, Inc. (1)
Endo International plc (1)
Evolus, Inc. (2)
Exactus, Inc. (1)
EYEGATE PHARMACEUTICALS INC (1)
GRAYBUG VISION, INC. (1)
Harmony Biosciences Holdings, Inc. (2)
HARVEST HEALTH & RECREATION INC. (1)
Horizon Pharma plc (1)
iANTHUS CAPITAL HOLDINGS, INC. (1)
IMARA Inc. (2)
INNOVATE BIOPHARMACEUTICALS, INC. (4)
Kaleido Biosciences, Inc. (1)
Landos Biopharma, Inc. (1)
Lannett Company, Inc. (1)
Level Brands, Inc. (4)
Liquidia Corp (1)
Lyra Therapeutics, Inc. (1)
Mallinckrodt (1)
Merck (1)
MJ Holdings, Inc. (1)
Mylan N.V. (6)
MYnd Analytics, Inc. (2)
NEKTAR THERAPEUTICS (1)
Neuralstem, Inc. (1)
Novan, Inc. (2)
OCULAR THERAPEUTIX, INC (3)
Onconova Therapeutics, Inc. (1)
One World Pharma, Inc. (1)
Organon & Co. (1)
Petros Pharmaceuticals, Inc. (1)
Pfizer (5)
Phathom Pharmaceuticals, Inc. (1)
Phibro Animal Health Corporation (1)
Recro Pharma, Inc. (2)
RELMADA THERAPEUTICS, INC. (1)
Revance Therapeutics, Inc. (4)
scPharmaceuticals Inc. (1)
SenesTech, Inc. (2)
Sienna Biopharmaceuticals, Inc. (3)
Sonoma Pharmaceuticals, Inc. (2)
Teligent, Inc. (1)
Terra Tech Corp. (6)
TETRAPHASE PHARMACEUTICALS INC (1)
TEVA PHARMACEUTICAL INDUSTRIES LTD (1)
Textmunication Holdings, Inc. (2)
The Medicines Company (1)
Theravance Biopharma, Inc. (1)
Tilray, Inc. (4)
Upjohn Inc (5)
Vitality Biopharma, Inc. (1)
XERIS PHARMACEUTICALS INC (1)
Zomedica Pharmaceuticals Corp. (3)

Recent Contracts

Transition and Separation Agreement, dated June 15, 2022, by and among ATAI Life Sciences US, Inc., ATAI Life Sciences N.V. and Greg Weaver (ATAI Life Sciences B.V., Filed With SEC on June 17, 2022)
Separation Agreement dated June 11, 2022 (Level Brands, Inc., Filed With SEC on June 14, 2022)
Separation Agreement dated June 11, 2022 (Level Brands, Inc., Filed With SEC on June 13, 2022)
Separation Agreement and Release dated as of May 18, 2022 (Adamis Pharmaceuticals Corp, Filed With SEC on May 19, 2022)
Separation Agreement, dated May 17, 2022, between Aquestive Therapeutics, Inc. and Keith J. Kendall (Aquestive Therapeutics, Inc., Filed With SEC on May 17, 2022)
Separation Agreement and General Release by and among the Company, iAnthus Capital Management, LLC and Randy Maslow dated April 28, 2022 (iANTHUS CAPITAL HOLDINGS, INC., Filed With SEC on May 12, 2022)
Separation Agreement dated February 25, 2022 by and between Revance Therapeutics, Inc. and Abhay Joshi (Revance Therapeutics, Inc., Filed With SEC on May 10, 2022)
Separation Agreement and General Release of Claims, dated as of March 3, 202 (Evolus, Inc., Filed With SEC on May 10, 2022)
Separation Agreement and General Release, dated as of April 21, 2022, by and between the Registrant and Kenneth M. Attie, M.D (IMARA Inc., Filed With SEC on May 6, 2022)
Separation Agreement between the Company and Francis Knuettel II, dated April 12, 2022 (Terra Tech Corp., Filed With SEC on April 15, 2022)